HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Afshin Derakhshani Selected Research

Immune Checkpoint Proteins

5/2022Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy.
4/2022The expression pattern of VISTA in the PBMCs of relapsing-remitting multiple sclerosis patients: A single-cell RNA sequencing-based study.
4/2021Pancreatic Cancer Signaling Pathways, Genetic Alterations, and Tumor Microenvironment: The Barriers Affecting the Method of Treatment.
1/2021A Systematic Review of the Tumor-Infiltrating CD8+ T-Cells/PD-L1 Axis in High-Grade Glial Tumors: Toward Personalized Immuno-Oncology.
1/2021A Systematic Review on PD-1 Blockade and PD-1 Gene-Editing of CAR-T Cells for Glioma Therapy: From Deciphering to Personalized Medicine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Afshin Derakhshani Research Topics

Disease

24Neoplasms (Cancer)
05/2022 - 01/2019
7Breast Neoplasms (Breast Cancer)
05/2022 - 01/2019
5COVID-19
02/2022 - 01/2020
5Colorectal Neoplasms (Colorectal Cancer)
11/2021 - 07/2020
3Infections
02/2022 - 01/2020
3Melanoma (Melanoma, Malignant)
01/2021 - 07/2020
2Lymphoma (Lymphomas)
05/2022 - 10/2019
2Relapsing-Remitting Multiple Sclerosis
04/2022 - 07/2021
2Triple Negative Breast Neoplasms
06/2021 - 01/2021
2Glioma (Gliomas)
02/2021 - 01/2021
1Microsatellite Instability
11/2021
1Virus Diseases (Viral Diseases)
08/2021
1Autoimmune Diseases (Autoimmune Disease)
07/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
04/2021
1Inflammation (Inflammations)
03/2021
1Glioblastoma (Glioblastoma Multiforme)
01/2021
1Multiple Sclerosis
01/2021
1Carcinogenesis
12/2020
1Vitiligo
10/2020
1Lung Neoplasms (Lung Cancer)
07/2020
1Head and Neck Neoplasms (Head and Neck Cancer)
07/2020
1Renal Cell Carcinoma (Grawitz Tumor)
07/2020
1Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2020
1Hepatocellular Carcinoma (Hepatoma)
03/2020
1Opportunistic Infections (Opportunistic Infection)
10/2019
1Leukemia
10/2019

Drug/Important Bio-Agent (IBA)

8MicroRNAs (MicroRNA)IBA
01/2022 - 01/2019
6Immune Checkpoint InhibitorsIBA
11/2021 - 06/2020
5Immune Checkpoint ProteinsIBA
05/2022 - 01/2021
5RNA (Ribonucleic Acid)IBA
04/2022 - 01/2021
4CytokinesIBA
08/2021 - 01/2020
4B7-H1 AntigenIBA
07/2021 - 07/2020
3Biomarkers (Surrogate Marker)IBA
01/2022 - 04/2020
3VaccinesIBA
08/2021 - 01/2020
3Pharmaceutical PreparationsIBA
08/2021 - 01/2020
2Oncogene Proteins (Oncogene Protein)IBA
11/2021 - 04/2020
2LigandsIBA
11/2021 - 06/2020
2Transcription Factors (Transcription Factor)IBA
03/2021 - 01/2020
2ArginaseIBA
03/2021 - 01/2020
2Programmed Cell Death 1 ReceptorIBA
01/2021 - 06/2020
2Proteins (Proteins, Gene)FDA Link
11/2020 - 06/2020
2Cytotoxins (Cytolysins)IBA
11/2020 - 11/2020
2VenomsIBA
11/2020 - 11/2020
2NivolumabIBA
07/2020 - 06/2020
2avelumabIBA
07/2020 - 06/2020
2pembrolizumabIBA
07/2020 - 06/2020
2durvalumabIBA
07/2020 - 06/2020
2atezolizumabIBA
07/2020 - 06/2020
1Small Cytoplasmic RNAIBA
02/2022
1Untranslated RNA (Noncoding RNA)IBA
01/2022
1lime (calcium oxide)FDA Link
08/2021
1Interferon Type IIBA
08/2021
1Interleukin-17 (Interleukin 17)IBA
08/2021
1Fingolimod Hydrochloride (FTY720)FDA Link
07/2021
1Glatiramer Acetate (Copaxone)FDA Link
07/2021
1Dimethyl FumarateIBA
07/2021
1Interleukin-10 (Interleukin 10)IBA
06/2021
1Interleukin-2 (IL2)IBA
06/2021
1Capecitabine (Xeloda)FDA Link
05/2021
1Oxaliplatin (Eloxatin)FDA LinkGeneric
05/2021
1Proteoglycans (Proteoglycan)IBA
04/2021
1Fluorouracil (Carac)FDA LinkGeneric
03/2021
1Complementary DNA (cDNA)IBA
03/2021
1mesoglycanIBA
01/2021
1Neoplasm Antigens (Tumor Antigens)IBA
01/2021
1Hemoglobins (Hemoglobin)IBA
01/2021
1Mitogen-Activated Protein KinasesIBA
01/2021
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
01/2021
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2021
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2021
1Phosphotransferases (Kinase)IBA
12/2020
1Transforming Growth Factor beta (TGF-beta)IBA
11/2020
1Caspase 9IBA
11/2020
1Caspase 8 (Caspase-8)IBA
11/2020
1Metalloproteases (Metalloproteinases)IBA
11/2020
1Messenger RNA (mRNA)IBA
10/2020
1AntibodiesIBA
07/2020
1AntigensIBA
07/2020
1tremelimumabIBA
06/2020
1IpilimumabIBA
06/2020
1alpha7 Nicotinic Acetylcholine ReceptorIBA
03/2020
1Small Interfering RNA (siRNA)IBA
03/2020
1Sorafenib (BAY 43-9006)FDA Link
03/2020
1Antiviral Agents (Antivirals)IBA
01/2020
1Trastuzumab (Herceptin)FDA Link
01/2020
1human ERBB2 proteinIBA
01/2020
1SerpinsIBA
01/2020
1LipidsIBA
10/2019

Therapy/Procedure

14Therapeutics
05/2022 - 01/2019
9Immunotherapy
05/2022 - 01/2019
5Drug Therapy (Chemotherapy)
05/2022 - 01/2020
2Radiotherapy
05/2022 - 01/2021
2Precision Medicine
02/2022 - 01/2021
1Aftercare (After-Treatment)
07/2021
1Transplantation
10/2019
1Hematopoietic Stem Cell Transplantation
10/2019
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
10/2019